Nodular liver-gallbladder violation of how to do
Nodular liver-gallbladder violation of how to do
Answer:
(A) primary liver cancer in general classification
1. Diffuse reflected in the small nodules scattered evenly distributed throughout the liver nodules than the same size, generally no more than the size of the Gan Xiaoye, and almost always at the same time the existence of liver cirrhosis, liver or slightly smaller than normal, and liver cirrhosis is not easy The distinction is a rare type, accounting for about 5% of primary liver cancer, the rapid development and poor prognosis.
2. Blocky type can be divided into pure-block, block fusion-and multi-block type. Pure-block, a single cancer mass, a clear border or irregular, often incomplete or complete envelope, and some may be coated, one could often see the edge of a small mass of the satellite cancer nodules. Fusion-block, can be seen to Aikuai was centered around the invasive growth and the size of neighboring cancer nodules. Multi-block for more than two single-block or block integration, this type of primary liver cancer accounts for about 30%, with more due to liver cirrhosis, the better the prognosis.
3. Nodular tumor size for the majority of the nodules, prominent in the performance of the liver, throughout the liver, cirrhosis and more complicated. Tumor nodules were off-white or sallow, or red brown. Of this type can be divided into single-nodular, the integration of multi-nodular and nodular. All of this type of liver cancer accounts for about 2 / 3, poor prognosis.
4. Small-cancer means the cancer below 5cm in diameter (some people think that 3cm below), and there is a single, generally have a complete envelope, a low degree of malignancy, is basically an early liver cancer. High rates of surgical resection, a good prognosis.
(B) histological classification of primary liver cancer
Primary liver cancer are the main pathological type 3, that is, hepatocellular carcinoma ( “HCC”), bile duct cancer cell and hybrid liver cancer. Liver cells in our country accounts for about 90%, for which this section focuses on hepatocellular carcinoma.
